SCHEMBL502745

SCHEMBL502745

[CH2]C(O)CC#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27835177 1.00
SCHEMBL6968815 0.72
SCHEMBL1527654 0.72 ALDH1A1 (0.31)
SCHEMBL6138484 0.72
SCHEMBL196713 0.72
SCHEMBL8830908 0.69
SCHEMBL467469 0.69
SCHEMBL2375307 0.67
SCHEMBL3500359 0.67
SCHEMBL58309 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104853737-A ORAL CARE COMPOSITION CONTAINING IONIC LIQUIDS COLGATE PALMOLIVE CO 2015-08-19 CN claimed
CN-102020575-A Synthesis method of L-carnitine UNIV ZHEJIANG TECHNOLOGY 2011-04-20 CN claimed
WO-2006127024-A1 REAGENTS AND METHODS FOR LABELING TERMINAL OLEFINS EISAI CO. LTD. (JP) 2006-11-30 WO claimed
US-20060045846-A1 Reagents and methods for labeling terminal olefins EISAI R&D MANAGEMENT CO., LTD. (JP) 2006-03-02 US claimed
CN-209680104-U 3- cyano -2- hydroxypropyl-trimethyl ammonium chloride hydrolyzes pipe reaction device UNIV HUANGGANG NORMAL 2019-11-26 CN disclosed
EP-2949652-B1 Intermediates for the preparation of halichondrin B EISAI R&D MAN CO LTD (JP) 2019-08-07 EP disclosed
EP-2686441-B1 METHODS AND USES FOR PREDICTING RESPONSE TO ERIBULIN EISAI R&D MAN CO LTD (JP) 2019-05-08 EP disclosed
CN-109180615-A Intermediates for the preparation of analogs of halichondrin B 卫材R&D管理有限公司 2019-01-11 CN disclosed
CN-108997267-A Intermediates for the preparation of analogs of halichondrin B 卫材R&D管理有限公司 2018-12-14 CN disclosed
CN-108484441-A Levocarnitine intermediate L-(-)The synthetic method of chlorination 3- cyano -2- hydroxypropyl trimethylammonium amine 常州兰陵制药有限公司 2018-09-04 CN disclosed
US-RE46965-E1 Intermediates for the preparation of analogs of Halichondrin B EISAI R&D MANAGEMENT CO., LTD. (JP) 2018-07-24 US disclosed
CN-103562406-B Methods and compositions for predicting response to eribulin 卫材R&D管理有限公司 2018-03-27 CN disclosed
EP-1087960-A4 MACROCYCLIC ANALOGS AND METHODS OF THEIR USE AND PREPARATION EISAI CO LTD (JP) 2004-12-01 EP disclosed
WO-2004056817-A1 OXAZOLIDINONE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ASTRAZENECA AB (SE) 2004-07-08 WO disclosed
WO-2004048392-A1 OXAZOLIDINONE AND / OR ISOXAZOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS ASTRAZENECA AB (SE) 2004-06-10 WO disclosed
US-6469182-B1 HALICHONDRIN ANALOGS HAVING PHARMACEUTICAL ACTIVITY, SUCH AS ANTICANCER OR ANTIMITOTIC ACTIVITY EISAI CO., LTD. (JP) 2002-10-22 US disclosed
US-6365759-B1 ANTICARCINOGENIC AND ANTIMITOTIC AGENTS; STABLE; MELANOMA; LEUKEMIA; COLON; MAMMARY GLANDS; OVARIES; PROSTATE GLANDS; LUNGS EISAI CO., LTD. (JP) 2002-04-02 US disclosed
US-6214865-B1 Macrocyclic analogs and methods of their use and preparation EISAI CO., LTD. (JP) 2001-04-10 US disclosed
EP-1087960-A1 MACROCYCLIC ANALOGS AND METHODS OF THEIR USE AND PREPARATION EISAI CO., LTD. (JP) 2001-04-04 EP disclosed
WO-1999065894-A1 MACROCYCLIC ANALOGS AND METHODS OF THEIR USE AND PREPARATION EISAI CO., LTD. (JP) 1999-12-23 WO disclosed